10-Q
Quarterly Report
ALTO INGREDIENTS, INC.
ALTO
NASDAQ
CIK: 778164
File #: 000-21467
Balance Sheet
53 line items · 2 periods
XBRL
| Item | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Current Assets: | ||
Cash and cash equivalents | 26,778,000 | 35,469,000 |
Restricted cash | 393,000 | 742,000 |
Cash collateral balance | 393,000 | 742,000 |
Accounts receivable (net of allowance for credit losses of $38 and $23, respectively) | 65,461,000 | 58,217,000 |
Inventories | 50,609,000 | 49,914,000 |
Derivative instruments | 4,071,000 | 3,313,000 |
Commodity contracts | 4,071,000 | 3,313,000 |
Derivative Financial Instruments, Assets | 4,071,000 | 3,313,000 |
Derivative Financial Instruments, Assets - Level 1 | 4,071,000 | 3,313,000 |
Long-lived assets – Magic Valley | — | 19,397,000 |
Long-lived assets – Magic Valley - Level 3 | — | 19,397,000 |
Other current assets | 6,149,000 | 5,463,000 |
Total current assets | 153,461,000 | 153,118,000 |
Property and equipment, net | 212,624,000 | 214,742,000 |
Other Assets: | ||
Right of use operating lease assets, net | 19,416,000 | 20,553,000 |
Intangible assets, net | 8,142,000 | 4,509,000 |
Other assets | 8,566,000 | 8,516,000 |
Total other assets | 36,124,000 | 33,578,000 |
Total Assets | 402,209,000 | 401,438,000 |
Pekin Campus | 216,152,000 | 223,934,000 |
Marketing and distribution | 118,130,000 | 102,895,000 |
Western production | 46,470,000 | 44,992,000 |
Corporate and Other | 21,457,000 | 29,617,000 |
Current Liabilities: | ||
Accounts payable | 17,029,000 | 20,369,000 |
Accrued liabilities | 23,819,000 | 24,214,000 |
Current portion – operating leases | 4,968,000 | 4,851,000 |
Derivative instruments | 301,000 | 1,177,000 |
Commodity contracts | 301,000 | 1,177,000 |
Derivative Financial Instruments, Liabilities | 301,000 | 1,177,000 |
Level 1 - Derivative Financial Instruments, Liabilities | 301,000 | 1,177,000 |
Other current liabilities | 6,999,000 | 7,193,000 |
Total current liabilities | 53,116,000 | 57,804,000 |
Long-term debt | 110,664,000 | 92,904,000 |
Operating leases, net of current portion | 15,641,000 | 16,913,000 |
Other liabilities | 8,868,000 | 8,754,000 |
Total Liabilities | 188,289,000 | 176,375,000 |
Stockholders’ Equity: | ||
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of March 31, 2025 and December 31, 2024; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of March 31, 2025 and December 31, 2024; liquidation preference of $18,075 as of March 31, 2025 | 1,000 | 1,000 |
Common stock value | 77,000 | 77,000 |
Additional paid-in capital | 1,045,024,000 | 1,044,176,000 |
Accumulated other comprehensive income | 4,975,000 | 4,975,000 |
Accumulated deficit | (836,157,000) | (824,166,000) |
Total Stockholders’ Equity | 213,920,000 | 225,063,000 |
Preferred Stock | 1,000 | 1,000 |
Common Stock | 77,000 | 77,000 |
Additional Paid-In Capital | 1,045,024,000 | 1,044,176,000 |
Accumulated Deficit | (836,157,000) | (824,166,000) |
Accum. Other Comprehensive Income | 4,975,000 | 4,975,000 |
Total Liabilities and Stockholders’ Equity | 402,209,000 | 401,438,000 |